HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prarthana Thiagarajan Selected Research

Proteins (Proteins, Gene)

12/2015The hepatitis C revolution part 2: difficult-to-treat groups and experimental approaches.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Prarthana Thiagarajan Research Topics

Disease

3Non-alcoholic Fatty Liver Disease
02/2021 - 10/2018
2Liver Diseases (Liver Disease)
02/2020 - 10/2018
2Fibrosis (Cirrhosis)
10/2018 - 12/2015
2Hepatitis C
12/2015 - 12/2015
1Disease Progression
02/2021
1Type 2 Diabetes Mellitus (MODY)
10/2018
1Fatty Liver
10/2018
1Infections
12/2015
1Virus Diseases (Viral Diseases)
12/2015
1Stroke (Strokes)
04/2012
1Hemorrhage
04/2012
1Adenoma (Adenomas)
04/2012

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
02/2021 - 02/2020
2Antiviral Agents (Antivirals)IBA
12/2015 - 12/2015
1SolutionsIBA
02/2020
1Pharmaceutical PreparationsIBA
07/2019
1procollagen Type III-N-terminal peptide (PIIP)IBA
10/2018
1ProcollagenIBA
10/2018
1daclatasvirIBA
12/2015
1Proteins (Proteins, Gene)FDA Link
12/2015
1SofosbuvirIBA
12/2015
1Drug CombinationsIBA
12/2015
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2012

Therapy/Procedure

3Therapeutics
02/2021 - 12/2015
1Chemoprevention
04/2012